Patient Power®
Get Email Alerts!
Health Topics
Multiple Myeloma Health Center
Health Center Home Audio Programs Videos Conference Coverage
  • ASH 2012
    • Live Events Get the Latest
    Search by Keyword:
    Search by Health Topic:
    View all Health Topics >
    2/13/12

    A Monoclonal Antibody for Multiple Myeloma

    Dr. Robert Orlowski, head of the myeloma section at MD Anderson Cancer Center, explains how a new monoclonal antibody, elotuzumab, may help deliver targeted chemotherapy to myeloma cells; a treatment strategy that has proved successful in other blood cancers.

    Health Topics: Multiple Myeloma

    Get Email Updates:

    Get updated automatically when new content about Multiple Myeloma has been posted.
    Privacy Policy
    Multiple Myeloma

    Experts & Guests

    Robert Orlowski, M.D., Ph.D. Robert Orlowski, M.D., Ph.D.
    Professor in the Departments of Lymphoma/Myeloma and Experimental Therapeutics, MD Anderson Cancer Center
    Dr. Robert Z. Orlowski is Associate Professor in the Departments of Lymphoma/Myeloma and Experimental Therapeutics, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center in Houston, Texas. He is board-certified in internal medicine and medical oncology.  Dr. Orlowski earned his doctoral degree in molecular biophysics and biochemistry from Yale University and his medical degree from the... more >

    Transcript

    1. A Monoclonal Antibody for Multiple Myeloma

    Related Videos

    Dr. Sagar Lonial covers the range of drugs in clinical trials for Myeloma

    Watch Now
    Dr. Robert Orlowski explains the first protein kinase inhibitor being studied for myeloma, from ASH 2011

    Watch Now
    Jack Aiello, 17-year survivor, attended the meeting and gives us his take on news that's significant for patients.

    Watch Now